Creative Planning Horizon Therapeutics Public LTD CO Transaction History

Creative Planning

$101 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 16, 2023	SELL	$98.98 - $115.74 $6,433 - $7,523	-65 Reduced 0.93%	6,913 $799,000
Q2 2023 Jul 21, 2023	SELL	$96.34 - $112.38 $49,037 - $57,201	-509 Reduced 6.8%	6,978 $717,000
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $13,736 - $14,528	-128 Reduced 1.68%	7,487 $817,000
Q4 2022 Feb 10, 2023	BUY	$62.39 - $113.8 $34,127 - $62,248	547 Added 7.74%	7,615 $866,000
Q3 2022 Nov 03, 2022	SELL	$58.92 - $84.67 $91,679 - $131,746	-1,556 Reduced 18.04%	7,068 $437,000
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $459,646 - $673,608	5,789 Added 204.2%	8,624 $688,000
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $8,296 - $10,541	-96 Reduced 3.28%	2,835 $298,000
Q4 2021 Feb 11, 2022	BUY	$98.56 - $119.91 $34,397 - $41,848	349 Added 13.52%	2,931 $316,000
Q3 2021 Nov 10, 2021	BUY	$91.91 - $110.37 $459 - $551	5 Added 0.19%	2,582 $283,000
Q2 2021 Aug 04, 2021	SELL	$86.24 - $95.92 $1.52 Million - $1.69 Million	-17,662 Reduced 87.27%	2,577 $241,000
Q1 2021 Apr 30, 2021	SELL	$71.83 - $95.48 $94,528 - $125,651	-1,316 Reduced 6.11%	20,239 $1.86 Million
Q4 2020 Jan 29, 2021	SELL	$67.0 - $84.39 $206,628 - $260,258	-3,084 Reduced 12.52%	21,555 $1.58 Million
Q3 2020 Nov 05, 2020	BUY	$55.23 - $79.93 $556,166 - $804,895	10,070 Added 69.12%	24,639 $1.91 Million
Q2 2020 Jul 23, 2020	SELL	$30.2 - $56.98 $11,929 - $22,507	-395 Reduced 2.64%	14,569 $810,000
Q1 2020 May 05, 2020	SELL	$24.87 - $38.56 $198 - $308	-8 Reduced 0.05%	14,964 $443,000
Q4 2019 Jan 30, 2020	BUY	$25.43 - $36.67 $686 - $990	27 Added 0.18%	14,972 $542,000
Q3 2019 Nov 01, 2019	SELL	$23.0 - $27.97 $7,705 - $9,369	-335 Reduced 2.19%	14,945 $407,000
Q2 2019 Jul 26, 2019	BUY	$22.81 - $28.48 $348,536 - $435,174	15,280 New	15,280 $368,000

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account